Androgen activation of Wnt/β-catenin signaling is linked to tumor progression, with AR promoting nuclear translocation and interaction with T-cell factor (TCF) in bladder cancer cells (Li et al., 2013). This evidence concerns the gene AR and urinary bladder carcinoma.